Orofacial migraine and neurovascular orofacial pain—new insights into characteristics and classification

Orofacial migraine (OFM) and neurovascular orofacial pain (NVOP) are both recognized as migraine-related entities affecting the facial and orofacial regions, according to the International Classification of Orofacial Pain (ICOP). However, the distinction between these two conditions and the question of whether NVOP should be considered a separate entity remain subjects of ongoing debate. The aim of this study is to compare the diagnostic characteristics of OFM and NVOP to reassess whether they should continue to be classified as two distinct diagnoses. The cohort comprised 75 patients, 12 males and 63 females, 40 were diagnosed as NVOP and 35 as OFM according to ICOP criteria. Patients were recruited from the tertiary orofacial pain clinic in Hadassah Medical Center between the years 2016 to 2023. NVOP and OFM patients did not differ in age, sex, pain intensity and other pain characteristics. However, OFM patients have significantly more cranial autonomic signs (36.4%) than NVOP patients (10.3%), and also more migraine symptoms such as nausea and photophobia. (68.6% vs. 41%) OFM patients reported significantly more awakening from sleep (52.9%) than NVOP patients (26.3%). Also, OFM pain was concomitant with headache in about two third of cases (66.7%), compared to only a third (30.8%) of NVOP cases. Most NVOP patients have pain that mimics toothache (85%), rarely detected in OFM (11.4%). The diagnostic features of OFM and NVOP indicate that there are many similarities between the two. But also, unique features that allows for separating OFM and NVOP into two distinct diagnostic entities, in accordance with the ICOP classification. Inclusion of patients with associated headaches enhanced this separation, and suggests expanding the definition of ICOP and include it under OFM and NVOP. At present there is justification to maintain the separate ICOP classifications of NVOP and OFM, particularly for research purposes.

Orofacial migraine; Neurovascular orofacial pain; International classification of orofacial pain

[1] Sharav Y, Katsarava Z, Charles A. Facial presentations of primary headache disorders. Cephalalgia. 2017; 37: 714–719.

[2] International classification of orofacial pain, 1st edition (ICOP). Cephalalgia. 2020; 40: 129–221.

[3] May A, Benoliel R, Imamura Y, Pigg M, Baad-Hansen L, Svensson P, et al. Orofacial pain for clinicians: a review of constant and attack-like facial pain syndromes. Cephalalgia. 2023; 43: 3331024231187160.

[4] Ananthan S, Benoliel R. Chronic orofacial pain. Journal of Neural Transmission. 2020; 127: 575–588.

[5] Ziegeler C, Beikler T, Gosau M, May A. Idiopathic facial pain syndromes—an overview and clinical implications. Deutsches Ärzteblatt International. 2021; 118: 81–87.

[6] Handa S, Keith DA, Abou-Ezzi J, Rosèn A. Neuropathic orofacial pain: characterization of different patient groups using the ICOP first edition, in a tertiary level Orofacial Pain Clinic. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2021; 132: 653–661.

[7] Reina F, Salemi G, Capizzi M, Lo Cascio S, Marino A, Santangelo G, et al. Orofacial migraine and other idiopathic non-dental facial pain syndromes: a clinical survey of a social orofacial patient group. International Journal of Environmental Research and Public Health. 2023; 20: 6946.

[8] Canfora F, Ottaviani G, Calabria E, Pecoraro G, Leuci S, Coppola N, et al. Advancements in understanding and classifying chronic orofacial pain: key insights from biopsychosocial models and international classifications (ICHD-3, ICD-11, ICOP). Biomedicines. 2023; 11: 3266.

[9] Anita H, Asnely Putri F, Maulina T. The association between orofacial pain and depression: a systematic review. Journal of Pain Research. 2024; 17: 785–796.

[10] Rahardian MK, Putri FA, Maulina T. Association between orofacial pain and anxiety: a systematic review. Journal of Pain Research. 2024; 17: 1–10.

[11] Benoliel R, Elishoov H, Sharav Y. Orofacial pain with vascular-type features. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 1997; 84: 506–512.

[12] Benoliel R, Birman N, Eliav E, Sharav Y. The international classification of headache disorders: accurate diagnosis of orofacial pain? Cephalalgia. 2008; 28: 752–762.

[13] Benoliel R, Sharav Y. Pain remapping in migraine to the orofacial region. Headache. 2009; 49: 1353–1354.

[14] Benoliel R, Sharav Y, Eliav E. Neurovascular orofacial pain. The Journal of the American Dental Association. 2010; 141: 1094–1096.

[15] Haviv Y, Zini A, Keshet N, Almoznino G, Benoliel R, Sharav Y. Features of neurovascular orofacial pain compared to painful posttraumatic trigeminal neuropathy. Journal of Oral & Facial Pain and Headache. 2020; 34: 121–128.

[16] Lambru G, Elias LA, Yakkaphan P, Renton T. Migraine presenting as isolated facial pain: a prospective clinical analysis of 58 cases. Cephalalgia. 2020; 40: 1250–1254.

[17] Ziegeler C, May A. Facial presentations of migraine, TACs, and other paroxysmal facial pain syndromes. Neurology. 2019; 93: e1138–e1147.

[18] Agius AM, Jones NS, Muscat R. Prospective three-year follow up of a cohort study of 240 patients with chronic facial pain. The Journal of Laryngology & Otology. 2014; 128: 518–526.

[19] Daudia AT, Jones NS. Facial migraine in a rhinological setting. Clinical Otolaryngology & Allied Sciences. 2002; 27: 521–525.

[20] Yoon MS, Mueller D, Hansen N, Poitz F, Slomke M, Dommes P, et al. Prevalence of facial pain in migraine: a population-based study. Cephalalgia. 2010; 30: 92–96.

[21] Sharav Y, Haviv Y, Benoliel R. Orofacial migraine or neurovascular orofacial pain from pathogenesis to treatment. International Journal of Molecular Sciences. 2023; 24: 2456.

[22] Obermann M, Mueller D, Yoon MS, Pageler L, Diener H, Katsarava Z. Migraine with isolated facial pain: a diagnostic challenge. Cephalalgia. 2007; 27: 1278–1282.

[23] Patel ZM, Kennedy DW, Setzen M, Poetker DM, DelGaudio JM. “Sinus headache”: rhinogenic headache or migraine? An evidence-based guide to diagnosis and treatment. International Forum of Allergy & Rhinology. 2013; 3: 221–230.

[24] Kari E, DelGaudio JM. Treatment of sinus headache as migraine: the diagnostic utility of triptans. Laryngoscope. 2008; 118: 2235–2239.

[25] Benoliel R, Eliav E, Sharav Y. Classification of chronic orofacial pain: applicability of chronic headache criteria. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2010; 110: 729–737.

[26] Benoliel R, Eliav E, Sharav Y. Self-reports of pain-related awakenings in persistent orofacial pain patients. Journal of Orofacial Pain. 2009; 23: 330–338.

[27] Peng KP, Benoliel R, May A. A review of current perspectives on facial presentations of primary headaches. Journal of Pain Research. 2022; 15: 1613–1621.

[28] Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the united states: figures and trends from government health studies. Headache. 2018; 58: 496–505.

[29] Czerninsky R, Benoliel R, Sharav Y. Odontalgia in vascular orofacial pain. Journal of Orofacial Pain. 1999; 13: 196–200.

[30] Peñarrocha M, Bandrés A, Peñarrocha M, Bagán JV. Lower-half facial migraine: a report of 11 cases. Journal of Oral and Maxillofacial Surgery. 2004; 62: 1453–1456.

[31] Ohkubo T, Shibata M, Yamada Y, Kaya H, Takahashi H. Role of substance P in neurogenic inflammation in the rat incisor pulp and the lower lip. Archives of Oral Biology. 1993; 38: 151–158.

[32] Heyeraas KJ, Kvinnsland I. Tissue pressure and blood flow in pulpal inflammation. Proceedings of the Finnish Dental Society. 1992; 88: 393–401.

[33] Sharav Y, Benoliel R. Orofacial pain and headache. 2nd edn. Quintessence: Chicago. 2015.

[34] Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)—a prospective clinical study of SUNCT and SUNA. Brain. 2006; 129: 2746–2760.